Found: 12
Select item for more details and to access through your institution.
SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16610-8
- By:
- Publication type:
- Article
Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066524
- By:
- Publication type:
- Article
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 622, doi. 10.3390/cancers12030622
- By:
- Publication type:
- Article
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1069, doi. 10.3390/cancers11081069
- By:
- Publication type:
- Article
Direct Synthesis of Stable 1T‐MoS<sub>2</sub> Doped with Ni Single Atoms for Water Splitting in Alkaline Media.
- Published in:
- Small, 2022, v. 18, n. 16, p. 1, doi. 10.1002/smll.202107238
- By:
- Publication type:
- Article
SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy.
- Published in:
- Cell Division, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13008-023-00091-w
- By:
- Publication type:
- Article
Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.
- Published in:
- Oncology Letters, 2019, v. 17, n. 2, p. 2171
- By:
- Publication type:
- Article
Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 6, p. 1329, doi. 10.1007/s13402-022-00722-4
- By:
- Publication type:
- Article
SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2397, doi. 10.2147/OTT.S189536
- By:
- Publication type:
- Article
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 3395, doi. 10.2147/OTT.S157724
- By:
- Publication type:
- Article
Efficient image fusion with approximate sparse representation.
- Published in:
- International Journal of Wavelets, Multiresolution & Information Processing, 2016, v. 14, n. 4, p. -1, doi. 10.1142/S0219691316500247
- By:
- Publication type:
- Article
Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
- Published in:
- Oncology Reports, 2016, v. 35, n. 5, p. 2801, doi. 10.3892/or.2016.4685
- By:
- Publication type:
- Article